Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival in patients with stage I-III breast cancer.
Phase of Trial: Phase IV
Latest Information Update: 16 Dec 2015
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Dec 2015 Status changed from withdrawn prior to enrolment to completed.
- 16 Dec 2015 New trial record